106 related articles for article (PubMed ID: 10450020)
1. L-Histidinol attenuates Fanconi syndrome induced by ifosfamide in rats.
Badary OA
Exp Nephrol; 1999; 7(4):323-7. PubMed ID: 10450020
[TBL] [Abstract][Full Text] [Related]
2. Taurine attenuates fanconi syndrome induced by ifosfamide without compromising its antitumor activity.
Badary OA
Oncol Res; 1998; 10(7):355-60. PubMed ID: 10063969
[TBL] [Abstract][Full Text] [Related]
3. Glycine attenuates Fanconi syndrome induced by maleate or ifosfamide in rats.
Nissim I; Weinberg JM
Kidney Int; 1996 Mar; 49(3):684-95. PubMed ID: 8648909
[TBL] [Abstract][Full Text] [Related]
4. Melatonin attenuates ifosfamide-induced Fanconi syndrome in rats.
Sener G; Sehirli O; Yegen BC; Cetinel S; Gedik N; Sakarcan A
J Pineal Res; 2004 Aug; 37(1):17-25. PubMed ID: 15230864
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone attenuates ifosfamide-induced Fanconi syndrome in rats and enhances its antitumor activity in mice.
Badary OA
J Ethnopharmacol; 1999 Nov; 67(2):135-42. PubMed ID: 10619376
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol improves ifosfamide-induced Fanconi syndrome in rats.
Sehirli O; Sakarcan A; Velioğlu-Oğünç A; Cetinel S; Gedik N; Yeğen BC; Sener G
Toxicol Appl Pharmacol; 2007 Jul; 222(1):33-41. PubMed ID: 17481685
[TBL] [Abstract][Full Text] [Related]
7. L-Carnitine attenuates ifosfamide-induced carnitine deficiency and decreased intramitochondrial CoA-SH in rat kidney tissues.
Sayed-Ahmed MM
J Nephrol; 2011; 24(4):490-8. PubMed ID: 21404227
[TBL] [Abstract][Full Text] [Related]
8. Effect of L-histidinol on cisplatin nephrotoxicity in the rat.
Badary OA; Nagi MN; Al-Sawaf HA; Al-Harbi M; Al-Bekairi AM
Nephron; 1997; 77(4):435-9. PubMed ID: 9434066
[TBL] [Abstract][Full Text] [Related]
9. Carnitine deficiency and oxidative stress provoke cardiotoxicity in an ifosfamide-induced Fanconi Syndrome rat model.
Sayed-Ahmed MM; Darweesh AQ; Fatani AJ
Oxid Med Cell Longev; 2010; 3(4):266-74. PubMed ID: 20972373
[TBL] [Abstract][Full Text] [Related]
10. Efforts to establish an animal model of Fanconi syndrome after ifosfamide administration to rats.
Appenroth D; Werner T; Lupp A; Patzer L; Misselwitz J; Fleck C
J Appl Toxicol; 2007; 27(4):327-36. PubMed ID: 17265418
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of oxidative and nitrosative apoptotic signaling by L-carnitine in Ifosfamide-induced Fanconi syndrome rat model.
Sayed-Ahmed MM; Hafez MM; Aldelemy ML; Aleisa AM; Al-Rejaie SS; Al-Hosaini KA; Al-Harbi NO; Al-Harbi MM; Al-Shabanah OA
Oxid Med Cell Longev; 2012; 2012():696704. PubMed ID: 23213347
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of gene expression of carnitine palmitoyltransferase I and heart fatty acid binding protein in cyclophosphamide and ifosfamide-induced acute cardiotoxic rat models.
Sayed-Ahmed MM; Aldelemy ML; Al-Shabanah OA; Hafez MM; Al-Hosaini KA; Al-Harbi NO; Al-Sharary SD; Al-Harbi MM
Cardiovasc Toxicol; 2014 Sep; 14(3):232-42. PubMed ID: 24469765
[TBL] [Abstract][Full Text] [Related]
13. Nephrotoxicity of ifosfamide in rats.
Springate JE; Van Liew JB
J Appl Toxicol; 1995; 15(5):399-402. PubMed ID: 8666724
[TBL] [Abstract][Full Text] [Related]
14. The Nephroprotective Role of Carnosine Against Ifosfamide-Induced Renal Injury and Electrolytes Imbalance is Mediated Via the Regulation of Mitochondrial Function and Alleviation of Oxidative Stress.
Ommati MM; Farshad O; Ghanbarinejad V; Mohammadi HR; Khadijeh M; Negar A; Zahra M; Ilkhaninasab F; Moezi L; Heidari R
Drug Res (Stuttg); 2020 Jan; 70(1):49-56. PubMed ID: 31671464
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of alpha lipoic acid versus N-acetylcysteine on ifosfamide-induced nephrotoxicity.
El-Sisi Ael-D; El-Syaad ME; El-Desoky KI; Moussa EA
Toxicol Ind Health; 2015 Feb; 31(2):97-107. PubMed ID: 23299189
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of daidzein against ifosfamide-induced neurotoxicity in male rats: role of selected inflammatory and apoptotic markers.
Hammoodi HZ; Al-Shawi NN
J Med Life; 2023 Nov; 16(11):1628-1632. PubMed ID: 38406792
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide-induced nephrotoxicity: mechanism and prevention.
Nissim I; Horyn O; Daikhin Y; Nissim I; Luhovyy B; Phillips PC; Yudkoff M
Cancer Res; 2006 Aug; 66(15):7824-31. PubMed ID: 16885387
[TBL] [Abstract][Full Text] [Related]
18. Estimation of ifosfamide/cisplatinum-induced renal toxicity by urinary protein analysis.
Rossi RM; Kist C; Wurster U; Külpmann WR; Ehrich JH
Pediatr Nephrol; 1994 Apr; 8(2):151-6. PubMed ID: 8018491
[TBL] [Abstract][Full Text] [Related]
19. Incorporating ifosfamide into salvia oil-based nanoemulsion diminishes its nephrotoxicity in mice inoculated with tumor.
AlMotwaa SM; Alkhatib MH; Alkreathy HM
Bioimpacts; 2020; 10(1):9-16. PubMed ID: 31988852
[No Abstract] [Full Text] [Related]
20. Intraperitoneal pretreatment of ellagic acid and chrysin alleviate ifosfamide-induced neurotoxicity, but betanin induces death in male wistar rats.
Salimi A; Shabani M; Mohammadi H; Sudi V
Hum Exp Toxicol; 2023; 42():9603271221147883. PubMed ID: 36951984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
